A Metabolic Endocrinology Pipeline Report on Hormone Replacement Therapy, With a Detailed Pipeline Overview and Analysis of Top Companies
Posted on: Thursday, 6 November 2008, 09:00 CST
Research and Markets (http://www.researchandmarkets.com/research/853434/metabolic_endocrin) has announced the addition of the "Metabolic Endocrinology - Hormone Replacement Therapy" report to their offering.
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Key Topics Covered:
- Hormone Replacement Therapy Pipeline Overview
- % of Projects (By Phase of Development)
- No. of Projects by Phase of Development
- Marketed Products Vs. Pipeline Products
- Company Overview
- Pipeline Projects
- Top Companies in late stage Hormone Replacement Therapy Projects
- Top Companies in early stage Hormone Replacement Therapy Projects
- Pipeline Revenue
- Full Pipeline View
- Pre Clinical Pipeline View
- Phase I Pipeline View
- Phase II Pipeline View
- Phase III Pipeline View
- Pending Approval Pipeline View
- On the Market Pipeline View
- Discovery/Development Pipeline View
For more information visit http://www.researchandmarkets.com/research/853434/metabolic_endocrin
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Yamana Provides Development Stage Projects Update
- Yamana Gold provides development and near development stage projects update
- An Essential Study of Innovations and Pipelines for Respiratory Disorders: Discover Niche Markets, New Products and Future Developments
- HUYA Bioscience Int'L Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
- View Details on the Top 20 Companies With Products in the Early Stage of Development for Non-Small-Cell Lung Cancer, Lung Cancer or Small Cell Lung Cancer
- IBM Maintains Worldwide Marketshare Leadership in Application Development Software According to Top Analyst Firm
- Indiana Health Information Exchange Selected to Participate in First Phase Development of RHIO Best Practices
- Pluristem Strengthens Business Strategy Company to Focus on Commercializing Cell Therapy Products
- Pluristem Strengthens Business Strategy, Company to Focus on Commercializing Cell Therapy Products
- INSTEON Alliance Reports Over 40 New Third Party INSTEON-Enabled Products in Active Development
 |
 |
User Comments (0)
RSS Feeds